Leverage Partners Absolute Return Fund SPC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,800
Closed -$1.88M 50
2022
Q3
$1.88M Buy
+5,800
New +$1.84M 2.4% 16

Other funds holding LLY

Leverage Partners Absolute Return Fund SPC's LLY Position: Q4 2022 in Review

Leverage Partners Absolute Return Fund SPC sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 5,800 shares — an estimated $1.88M sold.

Leverage Partners Absolute Return Fund SPC first reported a position in LLY in Q3 2022 and held it in 1 quarter. The position peaked at $1.88M in Q3 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Leverage Partners Absolute Return Fund SPC reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Leverage Partners Absolute Return Fund SPC sold 5,800 Eli Lilly shares in Q4 2022, an estimated $1.88M.
  • Leverage Partners Absolute Return Fund SPC first reported a position in Eli Lilly in Q3 2022 and held it in 1 quarter.
  • Leverage Partners Absolute Return Fund SPC's Eli Lilly position peaked at $1.88M in Q3 2022.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Leverage Partners Absolute Return Fund SPC's 13F filing for Q4 2022, filed 7 Feb 2023.